Latest 8-K filings

Sunrise Realty Trust, Inc. announced its second quarter 2026 financial results, reporting GAAP net income of $3.1 million and Distributable Earnings of $3.9 million, while maintaining current loan status and exceeding dividends with earnings.

Distribution Solutions Group announced strong second quarter 2026 results with revenue up 11.0% year-over-year, alongside improved profitability, while also confirming a definitive merger agreement to go private.

BioVie Inc. announced positive topline results from its Phase 2 SUNRISE-PD trial evaluating bezisterim for early-stage Parkinson's disease, showing significant improvements in motor and non-motor symptoms and a favorable safety profile.

Payoneer Global Inc. announced its second quarter 2026 financial results, highlighting a 10% revenue increase (excluding interest income) and 15% volume growth, while also confirming its agreement to be acquired by Nuvei.

Sunstone Hotel Investors announced robust second-quarter results, exceeding expectations, and raised its full-year financial outlook following the sale of a San Francisco hotel and strategic share repurchases.

Climb Bio reported Q2 2026 financial results, highlighting progress in its CLYM116 and budoprutug programs, with key data readouts and trial initiations expected, alongside an extended cash runway into late 2028.

Ingles Markets, Inc. announced robust financial results for the first nine months of fiscal 2026, showcasing significant net income growth and increased gross profit, alongside a reduction in total debt.

ITT Inc. reported record Q2 revenue of $1.5 billion, up 51% year-over-year, driven by the SPX FLOW acquisition and organic growth, leading to raised full-year guidance.

Lexicon Pharmaceuticals announced second quarter 2026 financial results, highlighting completed enrollment in its SONATA-HCM study and progress on its ZYNQUISTA NDA resubmission.

MACOM Technology Solutions Holdings, Inc. announced robust financial results for its fiscal third quarter ended July 3, 2026, showcasing substantial revenue and profit growth.

Collegium Pharmaceutical announced strong second-quarter 2026 results, with net revenues up 6% year-over-year, driven by significant growth in its ADHD portfolio, particularly JORNAY PM, and the successful acquisition of AZSTARYS.

Cronos Group Inc. announced record net revenue, gross profit, and Adjusted EBITDA for Q2 2026, driven by strong performance in Canada, Israel, and Germany, alongside a significant share repurchase program.

Optimum Communications announced its second quarter 2026 financial results, reporting a year-over-year revenue decrease of 5.8% to $2.02 billion and a net loss of $291.8 million.

Cheniere Energy Partners, L.P. announced robust second quarter 2026 financial results, including significant increases in revenue, net income, and Adjusted EBITDA, while reconfirming full-year distribution guidance.

Installed Building Products announced second quarter 2026 results, showing record revenue of $777.8 million, a 2.3% increase year-over-year, alongside a regular quarterly cash dividend declaration.

RE/MAX Holdings, Inc. and The Real Brokerage Inc. provide an update on their merger, detailing director appointments, committee structures, and upcoming shareholder meetings.

Cheniere Energy reported strong second quarter 2026 results, highlighted by operational milestones and a significant increase in full-year financial guidance for Adjusted EBITDA and Distributable Cash Flow.

The Dixie Group reported stable net sales for Q2 2026, with modest improvements in gross profit margins, though net income per diluted share decreased slightly year-over-year.

Curtiss-Wright Corporation announced robust second quarter 2026 financial results, exceeding expectations and leading to an upward revision of its full-year financial guidance.

Genie Energy reported a substantial increase in net income and EPS for Q2 2026, driven by improved gross margins in its retail energy segment.

Compass Therapeutics announced its second quarter 2026 financial results, detailing progress in its oncology drug pipeline and maintaining a cash runway into 2028.

Priority Technology Holdings, Inc. announced its second quarter 2026 financial results, showcasing a 9.4% year-over-year revenue increase to $262.3 million and affirming its full-year 2026 financial guidance.

Nuvation Bio announced robust second quarter 2026 financial results, showcasing significant revenue growth for IBTROZI and positive advancements in its safusidenib clinical program.

Genesis Energy LP announced robust second quarter 2026 financial results, marked by a significant increase in net income and cash flow, alongside strategic balance sheet enhancements.

Six Flags Entertainment Corporation reported its 2026 second-quarter results, highlighting increased attendance and Adjusted EBITDA on a same-park basis, alongside growth in its active pass base.

Safe Pro Group Inc. announced a new $780,000 purchase order from a Department of War Prime Contractor for AI-powered threat detection and drones.

ConocoPhillips announced robust second-quarter 2026 financial and operational results, highlighted by a significant increase in earnings, substantial cash flow generation, and a doubling of share repurchases.

The Dixie Group, Inc. has released an updated investor presentation highlighting its focus on the high-end residential flooring market, while acknowledging significant industry challenges and ongoing cost reduction efforts.

Tarsus Pharmaceuticals announced robust second quarter 2026 financial results, with XDEMVY net sales surging 69% year-over-year, leading to an increased full-year sales forecast and strategic pipeline expansion.

Nuveen Churchill Direct Lending Corp. reported Q2 2026 net investment income of $0.41 per share, declared a $0.38 per share distribution, and took strategic steps to optimize its balance sheet.